Pharmacology

Sigmund honored with 2013 Regents Award for Faculty Excellence

Regents awards recognize contributions to public higher education
Given by the Board of Regents, State of Iowa, the award honors faculty members for work representing a significant contribution to excellence in public education.  Dr. Sigmund is one of six awardees. Each honoree will receive $1,000.


Curt Sigmund, Department of Pharmacology
Sigmund came to the UI in 1991 as founding director of the UI Transgenic and Gene Targeting Facility, a high technology core service facility for biomedical researchers that has brought an estimated $10 million in grant funding to the College of Medicine annually.

While directing the facility for 21 years, he also established and sustained a vigorous research program on the molecular basis of hypertension. Through innovations including the use of genetically manipulated mice as a platform for studying the physiological genomics of hypertension, he has transformed investigation in the angiotensin and hypertension fields.

Many of the dozens of graduate students, postdoctoral fellows, research scientists, and young faculty he has mentored have emerged as academic and scientific leaders. In 2008 Sigmund was named to the Roy J. Carver Chair in Hypertension Research, and in 2010 he was appointed head of the Department of Pharmacology. In 2009 he received the American Heart Association’s Novartis Award in Hypertension Research, the pre-eminent award given in the field.

Featured in the IowaNow: http://now.uiowa.edu/2013/05/ui-faculty-honored-excellence

.